Home › Cardiovascular Disease › Georgia › Sandy Springs
Cardiovascular Disease clinical trials in Sandy Springs, GA
5 studies for Cardiovascular Disease are looking for participants at sites in and around Sandy Springs (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Urban Family Practice Associates, PC, Marietta · 10 mi away
- Atlanta Heart Specialists, LLC, Tucker · 10 mi away
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Atlanta Heart Specialists LLC, Tucker · 10 mi away
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Tucker · 10 mi away
Global Paradise System US Post Approval Study
RecruitingObservational study
- Wellstar Kennestone Hospital, Marietta · 10 mi away
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Recruiting
- WellStar Kennestone Hospital, Marietta · 10 mi away
Cardiovascular Disease trials in other cities
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Atlanta, GA22 studies
- Cleveland, OH22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- San Francisco, CA18 studies
Other studies in Sandy Springs
- Non-Small Cell Lung Cancer9 studies
- Steatotic Liver Disease6 studies
- Obesity6 studies
- Overweight5 studies
- Type 2 Diabetes5 studies
- Heart Failure5 studies
- Depression4 studies
- Stroke4 studies
- Hidradenitis Suppurativa3 studies
- Coronary Artery Disease3 studies
- Multiple Sclerosis3 studies
- Lung Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.